71 related articles for article (PubMed ID: 3332017)
1. Proteins encoded by the c-myc oncogene: analysis of c-myc protein degradation.
Lüscher B; Eisenman RN
Princess Takamatsu Symp; 1986; 17():291-301. PubMed ID: 3332017
[TBL] [Abstract][Full Text] [Related]
2. Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry.
Mohamed AN; Nakeff A; Mohammad RM; KuKuruga M; al-Katib A
Oncogene; 1988 Oct; 3(4):429-35. PubMed ID: 3152600
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of c-myc and N-myc produces distinct changes in nuclear fine structure and chromatin organization.
Henriksson M; Classon M; Ingvarsson S; Koskinen P; Sümegi J; Klein G; Thyberg J
Oncogene; 1988 Nov; 3(5):587-93. PubMed ID: 3078963
[TBL] [Abstract][Full Text] [Related]
4. Expression of the c-myc oncoprotein in human metaplastic epithelial cells of fibrocystic disease.
Papamichalis G; Francia K; Karachaliou FE; Anastasiades OT; Spandidos DA
Anticancer Res; 1988; 8(6):1217-22. PubMed ID: 3064712
[TBL] [Abstract][Full Text] [Related]
5. A quantitative analysis of modulations occurring in cellular c-myc protein content, %S phase and growth balance under growth-inhibitory conditions.
Engelhard HH
Cell Mol Biol (Noisy-le-grand); 1993 Sep; 39(6):607-20. PubMed ID: 8220071
[TBL] [Abstract][Full Text] [Related]
6. Human N-myc is closely related in organization and nucleotide sequence to c-myc.
Kohl NE; Legouy E; DePinho RA; Nisen PD; Smith RK; Gee CE; Alt FW
Nature; 1986 Jan 2-8; 319(6048):73-7. PubMed ID: 3510398
[TBL] [Abstract][Full Text] [Related]
7. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
8. Fluctuations and ultrastructural localization of oncoproteins and cell cycle regulatory proteins during growth and apoptosis of synchronized AGF cells.
Gazitt Y; Erdos GW
Cancer Res; 1994 Feb; 54(4):950-6. PubMed ID: 7906198
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
Krajewski S; Chatten J; Hanada M; Reed JC
Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790
[TBL] [Abstract][Full Text] [Related]
10. Correlation between c-myc protein expression and phases of the cell cycle in human colorectal carcinomas.
Sato H; Tsuchiya A; Abe R
Fukushima J Med Sci; 1995 Dec; 41(2):111-23. PubMed ID: 8823991
[TBL] [Abstract][Full Text] [Related]
11. A cell culture model system for genetic analyses of the cell cycle by targeted homologous recombination.
Prouty SM; Hanson KD; Boyle AL; Brown JR; Shichiri M; Follansbee MR; Kang W; Sedivy JM
Oncogene; 1993 Apr; 8(4):899-907. PubMed ID: 8455944
[TBL] [Abstract][Full Text] [Related]
12. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program.
Elliott K; Ge K; Du W; Prendergast GC
Oncogene; 2000 Sep; 19(41):4669-84. PubMed ID: 11032017
[TBL] [Abstract][Full Text] [Related]
13. Proto-oncogene expression in human glomerular diseases.
Takemura T; Okada M; Akano N; Murakami K; Hino S; Yagi K; Takekoshi Y; Yoshioka K
J Pathol; 1996 Mar; 178(3):343-51. PubMed ID: 8778342
[TBL] [Abstract][Full Text] [Related]
14. Neonatal diethylstilbestrol treatment alters the estrogen-regulated expression of both cell proliferation and apoptosis-related proto-oncogenes (c-jun, c-fos, c-myc, bax, bcl-2, and bcl-x) in the hamster uterus.
Zheng X; Hendry WJ
Cell Growth Differ; 1997 Apr; 8(4):425-34. PubMed ID: 9101088
[TBL] [Abstract][Full Text] [Related]
15. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line.
Dmitrovsky E; Kuehl WM; Hollis GF; Kirsch IR; Bender TP; Segal S
Nature; 1986 Aug 21-27; 322(6081):748-50. PubMed ID: 3528861
[TBL] [Abstract][Full Text] [Related]
16. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation.
Prochownik EV; Kukowska J
Nature; 1986 Aug 28-Sep 3; 322(6082):848-50. PubMed ID: 3528863
[TBL] [Abstract][Full Text] [Related]
17. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
Volm M; Mattern J
Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
[TBL] [Abstract][Full Text] [Related]
18. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination.
Mateyak MK; Obaya AJ; Adachi S; Sedivy JM
Cell Growth Differ; 1997 Oct; 8(10):1039-48. PubMed ID: 9342182
[TBL] [Abstract][Full Text] [Related]
19. [Experimental study of the expression of c-myc, c-fos and proto-oncogenes on hypertrophic and scars].
Hu Z; Lou L; Luo S
Zhonghua Zheng Xing Wai Ke Za Zhi; 2002 May; 18(3):165-7. PubMed ID: 12189705
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis may be either suppressed or enhanced with strategic combinations of antineoplastic drugs or anti-IgM.
Lin CK; Nguyen TT; Morgan TL; Mei RL; Kaptein JS; Kalunta CI; Yen CF; Park E; Zou HY; Lad PM
Exp Cell Res; 1998 Oct; 244(1):1-13. PubMed ID: 9770343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
